Understanding caffeine consumption in Huntington’s Disease
Objective: The purpose of this study is to better understand the amount of caffeine consumption in people with HD and the subjective motivations and consequences…Analyzing early states of HD progression using a machine learning driven approach
Objective: Our aim is to build an early state HD progression model (EHDPM), a sub-model to Integrated Huntington’s Disease Progression Model (IHDPM) [1] to identify…VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE
Objective: to validate the use of accelerometers to quantify energy expenditure (EE) under controlled conditions for Huntington’s disease (HD) patients using Indirect Calorimetry (IC) as…Very long time persistent hyperCKemia as the first manifestation of McLeod syndrome
Objective: To present a case of McLeod syndrome (MLS) with isolated muscle involvement for many years, which developed late-onset chorea leading to disease diagnosis. Background:…Defining minimal clinically important differences in Huntington’s disease: An anchor-based approach
Objective: This study aims to estimate the longitudinal minimal clinically important difference (MCID) for HD-relevant, cognitive, motor, and functional outcome measures. We used the new…All that emerge is not Lupus
Objective: The aim of this article is to report a rare case of Huntington's disease (HD) in a patient with chorea and previous diagnosis of…Reversible chorea due to bilateral basal ganglia lesion in diabetic uremic patient
Objective: To report diabetic patient with chronic renal failure who developed sudden chorea movements associated with reversible bilateral basal ganglia lesion. Background: Acute movement disorder…Juvenile Huntington’s Disease in Tunisia: Clinical Diversity and Literature review
Objective: We conducted the first JHD clinical and molecular features in Tunisia and North Africa, contributing to better understanding the diverse manifestation of the disease…Cognitive profiling in a cohort of Huntington’s disease (HD) patients
Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…Mimics or multiplicity: two patients with a PSP phenotype and underlying genetic neurodegenerative disorders.
Objective: To describe a two cases of patients presenting with a PSP phenotype and genetic findings consisted with Huntington’s disease (HD) in one case and…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 20
- Next Page »